As a trusted partner in ocular research, Ace Therapeutics utilizes specialized technology platforms to provide comprehensive services supporting preclinical ocular studies. Our platform provides a variety of evaluation tools, from high-resolution imaging to precise functional testing, helping our clients gather reliable data for their preclinical studies and advancing their research in ophthalmic drug development.
Our platform integrates a variety of ophthalmic evaluation tools to support preclinical ocular studies. These technologies enable detailed structural and functional assessments of the eye, providing reliable data for research and development.
Key CapabilitiesSlit-Lamp Microscopy
Examination of the anterior segment and diagnosis of ocular surface and anterior eye diseases.
Optical Coherence Tomography (OCT)
High-resolution imaging of the retina and optic nerve.
Intraocular Pressure (IOP) Measurement
Monitoring eye pressure changes for glaucoma studies.
Fluorescein Angiography
Evaluating retinal vascular health and circulation.
Fundus Photography
Capturing images of the retina and optic disc.
Visual Acuity Testing
Assessing clarity and sharpness of vision.
Visual Behavioral Testing
Assessing visual function through behavioral responses.
Our platform provides reliable and flexible evaluation technologies to support preclinical ocular studies. These capabilities help streamline research workflows and deliver high-quality data for drug development and related studies.
Support preclinical ocular research through streamlined evaluation processes and comprehensive data collection.
Utilize mostly non-invasive techniques to minimize discomfort and reduce stress for research subjects.
Offer customized testing solutions tailored to meet diverse client needs and specific project requirements.
Utilizing diverse imaging and functional testing techniques, our platform supports the study of disease mechanisms and the monitoring of experimental models throughout research programs.
Our evaluation technologies help clients conduct comprehensive testing during the preclinical stage. These tools enable the assessment and selection of potential ophthalmic drug candidates with research-driven data.
Our platform is applicable across various ocular disease areas, providing specialized support for research in conditions such as glaucoma, dry eye disease (DED) and age-related macular degeneration (AMD).
We provide tailored solutions for preclinical ocular research, offering comprehensive support for your studies. Contact us to explore how our technologies can help with your research needs.
You can contact us any way that is convenient for you. We are available via email or our online contact form below. Please feel free to reach out with any questions or inquiries.
We would be happy to answer your questions.